Home › Companies › ALDEYRA THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and ALDEYRA THERAPEUTICS INC.’s Form 8-K, filed June 11, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 10, 2025: 5 items on ALDEYRA THERAPEUTICS INC.’s Form 8-K, filed June 11, 2025: 3 elected · 2 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore ALDEYRA THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are ALDEYRA THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 11, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Richard H. Douglas, Ph.D. | 21,052,870 | -- | -- | 5,895,494 | 18,670,405 | 78% | Elected | — |
| Elect Director: Gary M. Phillips, M.D. | 23,683,657 | -- | -- | 3,264,707 | 18,670,405 | 88% | Elected | — |
| Elect Director: Neal S. Walker, D.O. | 23,791,102 | -- | -- | 3,157,262 | 18,670,405 | 88% | Elected | — |
| 2. Ratification of Appointment of BDO USA, P.C | 44,860,758 | 653,760 | 104,251 | -- | -- | 99% | Approved | — |
| 3. Advisory Vote on Executive Compensation | 18,847,620 | 7,919,279 | 181,465 | -- | 18,670,405 | 70% | Approved | — |
Source: ALDEYRA THERAPEUTICS INC., Form 8-K, filed with the SEC on June 11, 2025 — read the filing on EDGAR.
Each item below shows how the 129 asset managers that disclosed a ALDEYRA THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Gary M. Phillips, M.D.
ALDEYRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Gary M. Phillips, M.D.”): 23,683,657 for, 3,264,707 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the following directors to serve as Class II directors until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 6,936,275 for, 530,285 withheld, 21,117 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,760,799 | 0 | 0 | 0 | For |
| BlackRock | 1,374,115 | 0 | 0 | 0 | For |
| Fidelity | 870,787 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 317,730 | Withhold |
| Federated Hermes | 0 | 0 | 0 | 191,902 | Withhold |
| Equitable | 150,144 | 0 | 0 | 0 | For |
| Charles Schwab | 137,946 | 0 | 0 | 0 | For |
| TIAA | 128,345 | 0 | 0 | 0 | For |
| AQR | 114,257 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 82,675 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,346 | 0 | 0 | 10,494 | Mixed |
| Global X | 29,296 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 25,448 | 0 | 0 | 0 | For |
| Pacific Life | 23,945 | 0 | 0 | 0 | For |
| Northern Trust | 21,827 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,145 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 21,117 | 0 | Abstain |
| John Hancock | 18,394 | 0 | 0 | 0 | For |
| Brighthouse | 16,862 | 0 | 0 | 0 | For |
| Nationwide | 16,641 | 0 | 0 | 0 | For |
| Voya | 13,924 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 0 | 0 | 9,920 | Withhold |
| ProShares | 9,606 | 0 | 0 | 0 | For |
| SEI | 9,200 | 0 | 0 | 0 | For |
| DWS | 7,876 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 3 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Neal S. Walker, D.O.
ALDEYRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Neal S. Walker, D.O.”): 23,791,102 for, 3,157,262 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the following directors to serve as Class II directors until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 6,936,275 for, 530,285 withheld, 21,117 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,760,799 | 0 | 0 | 0 | For |
| BlackRock | 1,374,115 | 0 | 0 | 0 | For |
| Fidelity | 870,787 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 317,730 | Withhold |
| Federated Hermes | 0 | 0 | 0 | 191,902 | Withhold |
| Equitable | 150,144 | 0 | 0 | 0 | For |
| Charles Schwab | 137,946 | 0 | 0 | 0 | For |
| TIAA | 128,345 | 0 | 0 | 0 | For |
| AQR | 114,257 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 82,675 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,346 | 0 | 0 | 10,494 | Mixed |
| Global X | 29,296 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 25,448 | 0 | 0 | 0 | For |
| Pacific Life | 23,945 | 0 | 0 | 0 | For |
| Northern Trust | 21,827 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,145 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 21,117 | 0 | Abstain |
| John Hancock | 18,394 | 0 | 0 | 0 | For |
| Brighthouse | 16,862 | 0 | 0 | 0 | For |
| Nationwide | 16,641 | 0 | 0 | 0 | For |
| Voya | 13,924 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 0 | 0 | 9,920 | Withhold |
| ProShares | 9,606 | 0 | 0 | 0 | For |
| SEI | 9,200 | 0 | 0 | 0 | For |
| DWS | 7,876 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 4 wordings of this item as funds reported it.
78% Majority: yes · of votes cast
Description as filed by funds: Election of three Class II Directors: Richard H. Douglas, Ph.D.
ALDEYRA THERAPEUTICS INC.’s own tally for this item (“Elect Director: Richard H. Douglas, Ph.D.”): 21,052,870 for, 5,895,494 withheld, per its Form 8-K filed June 11, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected the following directors to serve as Class II directors until the 2028 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal.”
Support: 78% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 6,665,218 for, 801,342 withheld, 21,117 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,760,799 | 0 | 0 | 0 | For |
| BlackRock | 1,374,115 | 0 | 0 | 0 | For |
| Fidelity | 870,787 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 317,730 | Withhold |
| Federated Hermes | 0 | 0 | 0 | 191,902 | Withhold |
| Equitable | 91,494 | 0 | 0 | 58,650 | Mixed |
| Charles Schwab | 137,946 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 128,345 | Withhold |
| AQR | 114,257 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 82,675 | 0 | 0 | 0 | For |
| Lincoln Financial | 32,346 | 0 | 0 | 46,494 | Mixed |
| Global X | 0 | 0 | 0 | 29,296 | Withhold |
| AIG/SunAmerica | 25,448 | 0 | 0 | 0 | For |
| Pacific Life | 23,945 | 0 | 0 | 0 | For |
| Northern Trust | 21,827 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,145 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 21,117 | 0 | Abstain |
| John Hancock | 18,394 | 0 | 0 | 0 | For |
| Brighthouse | 16,862 | 0 | 0 | 0 | For |
| Nationwide | 16,641 | 0 | 0 | 0 | For |
| Voya | 13,924 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 0 | 0 | 9,920 | Withhold |
| ProShares | 9,606 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 9,200 | Withhold |
| DWS | 7,876 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Combines 7 wordings of this item as funds reported it.
70% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s named executive officers.
ALDEYRA THERAPEUTICS INC.’s own tally for this item (“3. Advisory Vote on Executive Compensation”): 18,847,620 for, 7,919,279 against — passed, per its Form 8-K filed June 11, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement.”
Support: 70% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,760,799 | 0 | 0 | 0 | For |
| BlackRock | 1,374,115 | 0 | 0 | 0 | For |
| Fidelity | 870,787 | 0 | 0 | 0 | For |
| Dimensional | 0 | 317,730 | 0 | 0 | Against |
| Federated Hermes | 0 | 191,902 | 0 | 0 | Against |
| Equitable | 150,144 | 0 | 0 | 0 | For |
| Charles Schwab | 137,946 | 0 | 0 | 0 | For |
| TIAA | 128,345 | 0 | 0 | 0 | For |
| AQR | 114,257 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 82,675 | 0 | 0 | 0 | For |
| Lincoln Financial | 68,346 | 10,494 | 0 | 0 | Mixed |
| Global X | 0 | 29,296 | 0 | 0 | Against |
| AIG/SunAmerica | 25,448 | 0 | 0 | 0 | For |
| Pacific Life | 23,945 | 0 | 0 | 0 | For |
| Northern Trust | 21,827 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,145 | 0 | 0 | 0 | For |
| Jackson National | 0 | 21,117 | 0 | 0 | Against |
| John Hancock | 18,394 | 0 | 0 | 0 | For |
| Brighthouse | 16,862 | 0 | 0 | 0 | For |
| Nationwide | 13,843 | 2,798 | 0 | 0 | Mixed |
| Voya | 13,924 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 9,920 | 0 | 0 | Against |
| ProShares | 9,606 | 0 | 0 | 0 | For |
| SEI | 0 | 9,200 | 0 | 0 | Against |
| DWS | 7,876 | 0 | 0 | 0 | For |
Fund voting reports, all 38 managers: 6,891,061 for, 596,616 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 2,994,479 | 0 | 0 | 0 | For |
| ARDSLEY ADVISORY PARTNERS LP | 0 | 1,683,812 | 0 | 0 | Against |
| BlackRock | 1,455,323 | 8,638 | 0 | 0 | For |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 0 | 1,052,697 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 976,926 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 510,888 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 359,038 | 144,393 | 0 | 0 | Mixed |
| State Street | 494,051 | 39 | 0 | 0 | For |
| AQR | 473,829 | 0 | 0 | 0 | For |
| Invesco | 0 | 412,770 | 0 | 0 | Against |
| Northern Trust | 242,543 | 0 | 0 | 0 | For |
| Palo Alto Investors LP | 225,465 | 0 | 0 | 0 | For |
| WOODSTOCK CORP | 0 | 223,094 | 0 | 0 | Against |
| Federated Hermes | 0 | 192,499 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 144,784 | 0 | 0 | Against |
| Charles Schwab | 137,974 | 0 | 0 | 0 | For |
| Nuveen | 129,724 | 0 | 0 | 0 | For |
| Wellington | 0 | 85,464 | 0 | 0 | Against |
| Dimensional | 0 | 83,297 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 78,734 | 0 | 0 | 0 | For |
| STRS OHIO | 76,500 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 73,841 | 0 | 0 | 0 | For |
| Vanguard | 59,127 | 0 | 0 | 0 | For |
| AllianceBernstein | 58,650 | 0 | 0 | 0 | For |
| CIBC Private Wealth Group LLC | 51,458 | 0 | 0 | 0 | For |
Institutional-manager reports, all 106 managers: 8,925,692 for, 4,154,018 against, 1,000 unknown. Showing the 25 largest; see all in the interactive database.
99% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF BDO USA, P.C. AS ALDEYRA THERAPEUTICS, INC.'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.
ALDEYRA THERAPEUTICS INC.’s own tally for this item (“2. Ratification of Appointment of BDO USA, P.C”): 44,860,758 for, 653,760 against — passed, per its Form 8-K filed June 11, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of Appointment of BDO USA, P.C. The Company's stockholders ratified the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 39 asset managers below reported 7,487,677 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,760,799 | 0 | 0 | 0 | For |
| BlackRock | 1,374,115 | 0 | 0 | 0 | For |
| Fidelity | 870,787 | 0 | 0 | 0 | For |
| Dimensional | 317,730 | 0 | 0 | 0 | For |
| Federated Hermes | 191,902 | 0 | 0 | 0 | For |
| Equitable | 150,144 | 0 | 0 | 0 | For |
| Charles Schwab | 137,946 | 0 | 0 | 0 | For |
| TIAA | 128,345 | 0 | 0 | 0 | For |
| AQR | 114,257 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 82,675 | 0 | 0 | 0 | For |
| Lincoln Financial | 78,840 | 0 | 0 | 0 | For |
| Global X | 29,296 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 25,448 | 0 | 0 | 0 | For |
| Pacific Life | 23,945 | 0 | 0 | 0 | For |
| Northern Trust | 21,827 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,145 | 0 | 0 | 0 | For |
| Jackson National | 21,117 | 0 | 0 | 0 | For |
| John Hancock | 18,394 | 0 | 0 | 0 | For |
| Brighthouse | 16,862 | 0 | 0 | 0 | For |
| Nationwide | 16,641 | 0 | 0 | 0 | For |
| Voya | 13,924 | 0 | 0 | 0 | For |
| Prudential/PGIM | 9,920 | 0 | 0 | 0 | For |
| ProShares | 9,606 | 0 | 0 | 0 | For |
| SEI | 9,200 | 0 | 0 | 0 | For |
| DWS | 7,876 | 0 | 0 | 0 | For |
Showing the 25 largest of 39 asset managers. See all 39 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 59,895,588 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 6.28% |
| 2 | BlackRock | 2.29% |
| 3 | Fidelity | 1.45% |
| 4 | Dimensional | 0.53% |
| 5 | Federated Hermes | 0.32% |
| 6 | Equitable | 0.25% |
| 7 | Charles Schwab | 0.23% |
| 8 | TIAA | 0.21% |
| 9 | AQR | 0.19% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.14% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PERCEPTIVE ADVISORS LLC | 5.00% |
| 2 | ARDSLEY ADVISORY PARTNERS LP | 2.81% |
| 3 | BlackRock | 2.44% |
| 4 | KINGDON CAPITAL MANAGEMENT, L.L.C. | 1.76% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.63% |
| 6 | ADAR1 Capital Management, LLC | 0.85% |
| 7 | KENNEDY CAPITAL MANAGEMENT LLC | 0.84% |
| 8 | State Street | 0.82% |
| 9 | AQR | 0.79% |
| 10 | Invesco | 0.69% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Perceptive Advisors LLC | 8.14% | DEF14A |
| BlackRock | 6.24% | 13F |
| Vanguard Group | 6.21% | 13F |
| Todd C. Brady, M.D., Ph.D. | 6.20% | DEF14A |
| Knoll Capital Management, LLC | 6.00% | DEF14A |
| Stephen G. Machatha, Ph.D. | 1.73% | DEF14A |
| State Street | 1.71% | 13F |
| Dimensional Fund Advisors | 1.12% | 13F |
| Morgan Stanley | 0.93% | 13F |
| Invesco | 0.84% | 13F |
Percentages above are of 59,895,588 shares outstanding, as reported by ALDEYRA THERAPEUTICS INC. on its Form 10-Q dated May 12, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ALDEYRA THERAPEUTICS INC.’s 10-Q dated May 12, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At ALDEYRA THERAPEUTICS INC.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 129 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 703 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of Aldeyra Therapeutics, Inc.'s… — ALDEYRA THERAPEUTICS INC.'s filing reports the proposal as approved, with 70% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ALDEYRA THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 11, 2025.
ALDEYRA THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.